Evidence map›Paper›PMID 33113829›Full record

ArticleCancers2020

Evaluation of Carbon Ion Radiation-Induced Trismus in Head and Neck Tumors Using Dose-Volume Histograms.

Atsushi Musha, Hirofumi Shimada, Nobuteru Kubo, Hidemasa Kawamura, Naoko Okano, Yuhei Miyasaka, Hiro Sato, Katsuyuki Shirai, Jun-Ichi Saitoh, Satoshi Yokoo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Atsushi MushaGunma University Heavy Ion Medical Center, Maebashi, Gunma 371-8511, Japan.ORCID 0000-0002-5210-8764
Hirofumi ShimadaGunma University Heavy Ion Medical Center, Maebashi, Gunma 371-8511, Japan.
Nobuteru KuboGunma University Heavy Ion Medical Center, Maebashi, Gunma 371-8511, Japan.ORCID 0000-0002-0626-8142
Hidemasa KawamuraGunma University Heavy Ion Medical Center, Maebashi, Gunma 371-8511, Japan.ORCID 0000-0003-4899-1715
Naoko OkanoGunma University Heavy Ion Medical Center, Maebashi, Gunma 371-8511, Japan.
Yuhei MiyasakaGunma University Heavy Ion Medical Center, Maebashi, Gunma 371-8511, Japan.ORCID 0000-0001-5137-1862
Hiro SatoGunma University Heavy Ion Medical Center, Maebashi, Gunma 371-8511, Japan.
Katsuyuki ShiraiDepartment of Radiology, Jichi Medical University Hospital, Shimotsuke, Tochigi 329-0498, Japan.ORCID 0000-0003-2096-8847
Jun-Ichi SaitohDepartment of Radiation Oncology, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan.
Satoshi YokooDepartment of Oral and Maxillofacial Surgery/Plastic Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan.
Kazuaki ChikamatsuDepartment of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan.
Tatsuya OhnoGunma University Heavy Ion Medical Center, Maebashi, Gunma 371-8511, Japan.ORCID 0000-0002-6703-3144
Gunma University Hospital · JPGunma University · JPJichi Medical University · JPUniversity of Toyama · JP

Funding

Project Mirai Cancer Research Grants 2017Takeda Science Foundation 2017
6 · The paper itself

Abstract

Carbon ion radiotherapy (C-ion RT) provides a highly localized deposition of energy that can increase radiation doses to tumors while minimizing irradiation of adjacent normal tissues. For tumors located near the temporomandibular joint, C-ion RT-induced trismus may occur. However, the relationship between the carbon ion dose and the onset of trismus is unclear. In this prospective observational study, we assessed the trismus/carbon ion dose relationship using dose-volume histograms in 35 patients who received C-ion RT in their head and neck regions between 2010 and 2014. Trismus was evaluated in patients according to the Common Terminology Criteria for Adverse Events, version 4.0. All patients were treated with 57.6 or 64.0 Gy (relative biological effectiveness (RBE)) in 16 fractions, and the median follow-up time was 57 months. Grade 2 trismus was observed in six patients. The median onset time was 12 months. At maximum radiation doses, all masticatory muscles and coronoid processes, particularly the masseter muscle, were significantly different (

Indexed as

carbon ion radiotherapycarbon ion radiotherapy-induced trismushead and neck tumor

Identifiers

PMID33113829
PMCPMC7693287
OpenAlexW3093575144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.